Absci

Absci is a biotechnology company that uses artificial intelligence to revolutionize the process of creating new biologic drugs. They specialize in designing antibodies from scratch using computer algorithms, bypassing traditional methods that rely on existing antibody libraries. Absci’s platform combines AI-driven design with rapid experimental validation to significantly reduce the time and cost typically associated with bringing new drug candidates to clinical trials.